Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation

✍ Scribed by Harrington, A.R.; Armstrong, E.P.; Nolan, P.; Malone, D.C.

• Book ID: 120388067
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 72 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.03.1483